Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
ESMO Open|October 14, 2020
Thirteen-year analyses of medical oncology outpatient day clinic data: a changing fieldMaximilian Marhold, Thais Topakian, Hermine Agis, et al.
World Journal of Gastroenterology|July 2, 2010
Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trialJanja Ocvirk, Thomas Brodowicz, Fritz Wrba, et al.
Lancet (London, England)|September 22, 2009
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 studyTudor Ciuleanu, Thomas Brodowicz, Christoph Zielinski, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2020
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanibNicolas Penel, Olivier Mir, Jennifer Wallet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2023
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022Christian Rothermundt, Dimosthenis Andreou, Jean-Yves Blay, et al.
The Lancet. Oncology|October 19, 2016
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trialOlivier Mir, Thomas Brodowicz, Antoine Italiano, et al.
Pageof 9